Lavipharm S.A (LAVI) — Cash Flow Reinvestment Rate

Latest as of December 2022: 33.32x

Lavipharm S.A (LAVI) has a Cash Flow Reinvestment Rate of 33.32x as of December 2022, reinvesting €17.56 Million (capex €17.56 Million ) from operating cash flow of €527.00K. See Lavipharm S.A (LAVI) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

33.32x
(Capex + Investments) / Operating CF

Total Reinvested

€17.56 Million
Capex + Investments

Operating Cash Flow

€527.00K
EUR

Capital Expenditures

€17.56 Million
EUR

Lavipharm S.A Cash Flow Reinvestment Rate (2014–2024)

Historical reinvestment intensity for Lavipharm S.A across 11 annual periods. For the full cash flow conversion analysis, see how efficiently does Lavipharm S.A generate cash.

Annual Cash Flow Reinvestment Rate for Lavipharm S.A (2014–2024)

Year-by-year capital reinvestment analysis for Lavipharm S.A. See financial agility of Lavipharm S.A to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2024 4.13x €19.14 Million €4.64 Million €9.64 Million ▼ -84.4%
2023 26.43x €7.51 Million €284.00K €4.05 Million ▲ +24.2%
2022 21.28x €71.21 Million €3.35 Million €35.62 Million ▲ +2038.2%
2021 1.00x €3.80 Million €3.82 Million €1.92 Million ▼ -3.8%
2020 1.03x €2.95 Million €2.85 Million €1.48 Million ▲ +23.9%
2019 0.84x €2.42 Million €2.89 Million €2.42 Million ▲ +14.7%
2018 0.73x €1.03 Million €1.42 Million €1.03 Million ▲ +215.0%
2017 0.23x €350.00K €1.51 Million €350.00K ▲ +25.1%
2016 0.18x €112.00K €606.00K €97.00K ▲ +180.1%
2015 0.07x €38.00K €576.00K €23.00K ▼ -87.1%
2014 0.51x €1.22 Million €2.38 Million €1.20 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow